0001203311-16-000133.txt : 20160822
0001203311-16-000133.hdr.sgml : 20160822
20160822213823
ACCESSION NUMBER: 0001203311-16-000133
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160822
FILED AS OF DATE: 20160822
DATE AS OF CHANGE: 20160822
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cline Darren S
CENTRAL INDEX KEY: 0001633639
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 161846316
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2016-08-22
0
0001060736
SEATTLE GENETICS INC /WA
SGEN
0001633639
Cline Darren S
21823 30TH DRIVE SE
BOTHELL
WA
98021
0
1
0
0
EVP, Commercial
Common Stock
2016-08-22
4
S
0
1774.0
46.5907
D
40973
D
Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Includes 562 shares acquired under the Amended & Restated 2000 Employee Stock Purchase Plan on July 29, 2016.
/s/ Darren Cline
2016-08-22